These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 9212740)

  • 1. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis.
    Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
    Am J Pathol; 1997 Jul; 151(1):141-50. PubMed ID: 9212740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-10 is a mesangial cell growth factor in vitro and in vivo.
    Chadban SJ; Tesch GH; Foti R; Atkins RC; Nikolic-Paterson DJ
    Lab Invest; 1997 May; 76(5):619-27. PubMed ID: 9166281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
    Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction involved in protective effects of 15(R/S)-methyl- lipoxin A(4) on mesangioproliferative nephritis in rats.
    Wu SH; Wu XH; Liao PY; Dong L
    Prostaglandins Leukot Essent Fatty Acids; 2007 Mar; 76(3):173-80. PubMed ID: 17329090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
    Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
    J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
    Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
    Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis.
    Budisavljevic MN; Hodge L; Barber K; Fulmer JR; Durazo-Arvizu RA; Self SE; Kuhlmann M; Raymond JR; Greene EL
    Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1138-48. PubMed ID: 14600028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of experimental mesangial proliferative nephritis by interferon-gamma.
    Johnson RJ; Lombardi D; Eng E; Gordon K; Alpers CE; Pritzl P; Floege J; Young B; Pippin J; Couser WG
    Kidney Int; 1995 Jan; 47(1):62-9. PubMed ID: 7731171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.
    Panichi V; Migliori M; Taccola D; Filippi C; De Nisco L; Giovannini L; Palla R; Tetta C; Camussi G
    Kidney Int; 2001 Jul; 60(1):87-95. PubMed ID: 11422740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
    Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
    Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle-dependent interleukin 1 gene expression by cultured glomerular mesangial cells.
    Lovett DH; Larsen A
    J Clin Invest; 1988 Jul; 82(1):115-22. PubMed ID: 3260603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.
    Tam FW; Smith J; Cashman SJ; Wang Y; Thompson EM; Rees AJ
    Am J Pathol; 1994 Jul; 145(1):126-36. PubMed ID: 8030744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased collagen-degrading activity could be a marker of prolonged mesangial matrix expansion.
    Tomita M; Koike H; Han GD; Shimizu F; Kawachi H
    Clin Exp Nephrol; 2004 Mar; 8(1):17-26. PubMed ID: 15067512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis.
    Floege J; Eng E; Young BA; Couser WG; Johnson RJ
    Kidney Int; 1993 Feb; 43(2):369-80. PubMed ID: 8441232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [FTY720 attenuates rat anti-Thy-1 mesangial proliferative glomerulonephritis by inhibition of transforming growth factor β1-connective tissue growth factor pathway].
    Jiang JY; Huang XD; Wang Y; Deng AP; Zhou JH
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):107-11. PubMed ID: 22455887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.
    McKenzie RC; Oran A; Dinarello CA; Sauder DN
    Anticancer Res; 1996; 16(1):437-41. PubMed ID: 8615650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety.
    Burg M; Ostendorf T; Mooney A; Koch KM; Floege J
    Lab Invest; 1997 Apr; 76(4):505-16. PubMed ID: 9111513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis.
    Huijun W; Long C; Zhigang Z; Feng J; Muyi G
    Exp Mol Pathol; 2005 Feb; 78(1):17-24. PubMed ID: 15596056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective effects of 15-methyl-lipoxin A4 on mesangioproliferative nephritis in rats].
    Wu SH; Liao PY; Dong L; Jiang XY
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):225-30. PubMed ID: 16787597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.